← Back to Clinical Trials
Recruiting NCT07552311

NCT07552311 Generative AI Plan for Care Lab Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07552311
Status Recruiting
Phase
Sponsor Fitbit LLC
Condition Primary Health Care
Study Type INTERVENTIONAL
Enrollment 40,000 participants
Start Date 2025-11-21
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Fitbit Plan for Care LabBaseline Model

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40,000 participants in total. It began in 2025-11-21 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is an experimental study to observe participants' interactions with the Pre-visit Lab, and the output of various generative AI models that support consumer symptom queries and provide the user with information about possible urgency, potential causes or diagnoses based on the symptoms they disclose, and a summary of information to bring to a health care visit if planned.

Eligibility Criteria

Inclusion Criteria: 1. Age of majority: are of legal adult age (18 or older in most US states; 19 or older in Nebraska \& Alabama, or 21 or older in Mississippi) 2. Resides in the United States 3. Fitbit mobile user using their Google accounts on an Android smartphone 4. Able to read, write and willing to consent in English Exclusion Criteria: 1. Enrollment using a corporate google.com account 2. Have a condition or circumstance that the investigator determines as inappropriate for participation. 3. Have a chief complaint or symptoms that are potentially related to mental health disorders, sexually transmitted diseases or infections, or pregnancy.

Contact & Investigator

Central Contact

Bhavna Daryani, BDS

✉ bhavnad@google.com

📞 2018859852

Frequently Asked Questions

Who can join the NCT07552311 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Primary Health Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07552311 currently recruiting?

Yes, NCT07552311 is actively recruiting participants. Contact the research team at bhavnad@google.com for enrollment information.

Where is the NCT07552311 trial being conducted?

This trial is being conducted at Mountain View, United States.

Who is sponsoring the NCT07552311 clinical trial?

NCT07552311 is sponsored by Fitbit LLC. The trial plans to enroll 40,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology